Skip to main navigation Skip to search Skip to main content

Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma (Cell Death Discovery, (2020), 6, 1, (114), 10.1038/s41420-020-00348-1)

  • Surein Arulananda
  • , Megan O’Brien
  • , Marco Evangelista
  • , Tiffany J. Harris
  • , Nikita S. Steinohrt
  • , Laura J. Jenkins
  • , Marzena Walkiewicz
  • , Robert J.J. O’Donoghue
  • , Ashleigh R. Poh
  • , Bibhusal Thapa
  • , David S. Williams
  • , Trishe Leong
  • , John M. Mariadason
  • , Xia Li
  • , Jonathan Cebon
  • , Erinna F. Lee
  • , Thomas John
  • , W. Douglas Fairlie
  • Olivia Newton-John Cancer Research Institute
  • Austin Health
  • University of Melbourne
  • La Trobe University
  • Peter Maccallum Cancer Centre

Research output: Contribution to journalComment/debate

Fingerprint

Dive into the research topics of 'Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma (Cell Death Discovery, (2020), 6, 1, (114), 10.1038/s41420-020-00348-1)'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Nursing and Health Professions